ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2026
Application of Focused Ultrasound for the Treatment of Tendinopathy: An In Vivo Feasibility, Safety, and Efficacy Study.
Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Mechanical loading-based rehabilitation of tendinopathies improves symptoms and tendon biomechanics, motivating interest in non-invasive treatment options. Focused ultrasound (FUS) is a promising technology that precisely targets tissue regions, inducing desired bioeffects while minimally affecting surrounding tissues. To explore its potential for treating tendinopathies, we sequentially characterized FUS-induced tendon temperature elevations ex vivo, treated uninjured mouse Achilles tendons in vivo, and finally assessed the in vivo effects of FUS treatment of tendinopathic tissues. FUS (1.1 MHz transducer) consisted of thermal-dominant (0.5 MPa peak-peak pressure, continuous pulsing, 100% duty cycle) or mechanical-dominant (2 or 5 MPa, 10 Hz, 1% duty cycle) pulsing for four sessions over 1 week. No adverse events were observed, and mice did not exhibit pain or distress. Relative to untreated tendons, thermal FUS treatment of uninjured tendons did not alter mechanical properties while mechanical (5 MPa) FUS treatment significantly reduced maximum stress and elastic modulus. Tendons from both treatments exhibited mild matrix disorganization and increased cellularity, indicating an adaptive response. When applied to injured tendons, mechanical (5 MPa) FUS treatment reduced cross-sectional area and restored elastic modulus and yield stress to levels of naïve tendons. Although signs of injury persisted, the FUS-treated region exhibited fewer rounded cells and a reduction in sulfated glycosaminoglycan deposits, indicative of injury improvement. These pre-clinical studies demonstrate the safety, feasibility and preliminary efficacy of FUS for tendinopathy treatment. This foundational methodology facilitates further exploration of acoustic treatment parameters and strategies to augment tendon healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.